Wettig Thane, CEO of Kyntra Bio, Inc. ($KYNB), bought shares on the open market three times in the last year, totaling $84.4 thousand. His latest purchase occurred on November 17, 2025. These KYNB insider buys rank 2,558th among 4,983 individuals in our database, well below the average of $1.46 million and 3.3 transactions per buyer. Wettig Thane reported no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 6, 2026 | KYNTRA BIO, INC. | $KYNB | Wettig Thane | CEO | F | Common Stock | 277 | $6.84 | 24,443.0000 | 78,000,000 | 1.12% | 0.00% |
| Feb. 3, 2026 | KYNTRA BIO, INC. | $KYNB | Wettig Thane | CEO | A | Stock Option (Right to Buy) | 60000 | $0.00 | 60,000.0000 | 78,000,000 | 9999.99% | 0.08% |
| Dec. 6, 2025 | KYNTRA BIO, INC. | $KYNB | Wettig Thane | CEO | F | Common Stock | 259 | $8.42 | 24,720.0000 | 78,000,000 | 1.04% | 0.00% |
| Nov. 17, 2025 | KYNTRA BIO, INC. | $KYNB | Wettig Thane | CEO | P | Common Stock | 2700 | $9.10 | 24,979.0000 | 78,000,000 | 12.12% | 0.00% |
| Nov. 13, 2025 | KYNTRA BIO, INC. | $KYNB | Wettig Thane | CEO | P | Common Stock | 1000 | $9.18 | 22,279.0000 | 78,000,000 | 4.70% | 0.00% |
| Sept. 6, 2025 | KYNTRA BIO, INC. | $KYNB | Wettig Thane | CEO | F | Common Stock | 248 | $12.10 | 21,279.0000 | 101,100,000 | 1.15% | 0.00% |
| June 6, 2025 | KYNTRA BIO, INC. | $KYNB | Wettig Thane | CEO | F | Common Stock | 246 | $7.83 | 21,527.0000 | 100,917,000 | 1.13% | 0.00% |
| March 24, 2025 | KYNTRA BIO, INC. | $KYNB | Wettig Thane | CEO | P | Common Stock | 145000 | $0.35 | 544,329.0000 | 100,917,000 | 36.31% | 0.14% |
| March 6, 2025 | KYNTRA BIO, INC. | $KYNB | Wettig Thane | CEO | F | Common Stock | 367 | $0.39 | 399,329.0000 | 100,917,000 | 0.09% | 0.00% |
| March 6, 2025 | KYNTRA BIO, INC. | $KYNB | Wettig Thane | CEO | A | Common Stock | 781 | $0.00 | 399,696.0000 | 100,917,000 | 0.20% | 0.00% |
| March 6, 2025 | KYNTRA BIO, INC. | $KYNB | Wettig Thane | CEO | F | Common Stock | 22038 | $0.39 | 398,915.0000 | 100,917,000 | 5.24% | 0.02% |
| Jan. 9, 2025 | KYNTRA BIO, INC. | $KYNB | Wettig Thane | CEO | A | Stock Option (Right to Buy) | 1300000 | $0.00 | 1,300,000.0000 | 100,917,000 | 9999.99% | 1.29% |
| Dec. 6, 2024 | KYNTRA BIO, INC. | $KYNB | Wettig Thane | CEO | F | Common Stock | 2363 | $0.34 | 420,953.0000 | 98,770,000 | 0.56% | 0.00% |
| Sept. 6, 2024 | KYNTRA BIO, INC. | $KYNB | Wettig Thane | CEO | F | Common Stock | 2363 | $0.39 | 423,316.0000 | 98,770,000 | 0.56% | 0.00% |
| Aug. 1, 2024 | KYNTRA BIO, INC. | $KYNB | Wettig Thane | CEO | F | Common Stock | 20840 | $0.47 | 425,679.0000 | 98,770,000 | 4.67% | 0.02% |
| June 22, 2024 | KYNTRA BIO, INC. | $KYNB | Wettig Thane | CEO | F | Common Stock | 782 | $1.13 | 446,519.0000 | 98,770,000 | 0.17% | 0.00% |
| June 6, 2024 | KYNTRA BIO, INC. | $KYNB | Wettig Thane | CEO | F | Common Stock | 2255 | $1.19 | 447,301.0000 | 98,770,000 | 0.50% | 0.00% |
| May 1, 2024 | KYNTRA BIO, INC. | $KYNB | Wettig Thane | CEO | F | Common Stock | 20840 | $1.17 | 449,556.0000 | 98,770,000 | 4.43% | 0.02% |
| March 22, 2024 | KYNTRA BIO, INC. | $KYNB | Wettig Thane | CEO | F | Common Stock | 782 | $2.58 | 470,396.0000 | 98,770,000 | 0.17% | 0.00% |
| March 7, 2024 | KYNTRA BIO, INC. | $KYNB | Wettig Thane | CEO | P | Common Stock | 50000 | $1.91 | 471,178.0000 | 98,770,000 | 11.87% | 0.05% |
| March 6, 2024 | KYNTRA BIO, INC. | $KYNB | Wettig Thane | CEO | A | Common Stock | 781 | $0.00 | 421,504.0000 | 98,770,000 | 0.19% | 0.00% |
| March 6, 2024 | KYNTRA BIO, INC. | $KYNB | Wettig Thane | CEO | F | Common Stock | 326 | $1.87 | 421,178.0000 | 98,770,000 | 0.08% | 0.00% |
| March 6, 2024 | KYNTRA BIO, INC. | $KYNB | Wettig Thane | CEO | F | Common Stock | 4209 | $1.87 | 420,723.0000 | 98,770,000 | 0.99% | 0.00% |
| Feb. 21, 2024 | KYNTRA BIO, INC. | $KYNB | Wettig Thane | CEO | A | Common Stock | 166000 | $0.00 | 424,932.0000 | 98,770,000 | 64.11% | 0.17% |
| Feb. 21, 2024 | KYNTRA BIO, INC. | $KYNB | Wettig Thane | CEO | A | Stock Option (Right to Buy) | 834000 | $0.00 | 834,000.0000 | 98,770,000 | 9999.99% | 0.84% |
| Feb. 1, 2024 | KYNTRA BIO, INC. | $KYNB | Wettig Thane | CEO | F | Common Stock | 23490 | $2.37 | 258,932.0000 | 98,770,000 | 8.32% | 0.02% |
| Dec. 22, 2023 | KYNTRA BIO, INC. | $KYNB | Wettig Thane | CEO | F | Common Stock | 819 | $0.76 | 282,422.0000 | 0 | 0.29% | 0.00% |
| Dec. 6, 2023 | KYNTRA BIO, INC. | $KYNB | Wettig Thane | CEO | F | Common Stock | 1680 | $0.58 | 283,241.0000 | 0 | 0.59% | 0.00% |
| Nov. 1, 2023 | KYNTRA BIO, INC. | $KYNB | Wettig Thane | CEO | F | Common Stock | 21841 | $0.55 | 284,921.0000 | 0 | 7.12% | 0.00% |
| Sept. 22, 2023 | KYNTRA BIO, INC. | $KYNB | Wettig Thane | Interim CEO | F | Common Stock | 819 | $0.79 | 306,762.0000 | 0 | 0.27% | 0.00% |
| Sept. 6, 2023 | KYNTRA BIO, INC. | $KYNB | Wettig Thane | Interim CEO | F | Common Stock | 1680 | $0.96 | 307,581.0000 | 0 | 0.54% | 0.00% |
| Aug. 7, 2023 | KYNTRA BIO, INC. | $KYNB | Wettig Thane | Chief Commercial Officer | A | Common Stock | 200000 | $0.00 | 308,261.0000 | 0 | 184.74% | 0.00% |
| Aug. 7, 2023 | KYNTRA BIO, INC. | $KYNB | Wettig Thane | Chief Commercial Officer | A | Stock Option (Right to Buy) | 300000 | $0.00 | 300,000.0000 | 0 | 9999.99% | 0.00% |
| June 23, 2023 | KYNTRA BIO, INC. | $KYNB | Wettig Thane | Chief Commercial Officer | S | Common Stock | 791 | $16.53 | 108,261.0000 | 0 | 0.73% | 0.00% |
| June 7, 2023 | KYNTRA BIO, INC. | $KYNB | Wettig Thane | Chief Commercial Officer | S | Common Stock | 1286 | $17.04 | 109,052.0000 | 0 | 1.17% | 0.00% |
| June 7, 2023 | KYNTRA BIO, INC. | $KYNB | Wettig Thane | Chief Commercial Officer | S | Common Stock | 472 | $17.04 | 110,338.0000 | 0 | 0.43% | 0.00% |
| June 7, 2023 | KYNTRA BIO, INC. | $KYNB | Wettig Thane | Chief Commercial Officer | S | Common Stock | 1286 | $17.04 | 111,395.0000 | 0 | 1.14% | 0.00% |
| June 7, 2023 | KYNTRA BIO, INC. | $KYNB | Wettig Thane | Chief Commercial Officer | S | Common Stock | 472 | $17.04 | 112,681.0000 | 0 | 0.42% | 0.00% |
| March 20, 2023 | KYNTRA BIO, INC. | $KYNB | Wettig Thane | Chief Commercial Officer | G | Common Stock | 1000 | $0.00 | 109,310.0000 | 0 | 0.92% | 0.00% |
| March 20, 2023 | KYNTRA BIO, INC. | $KYNB | Wettig Thane | Chief Commercial Officer | G | Common Stock | 2343 | $0.00 | 109,310.0000 | 0 | 2.10% | 0.00% |
| March 23, 2023 | KYNTRA BIO, INC. | $KYNB | Wettig Thane | Chief Commercial Officer | S | Common Stock | 905 | $18.71 | 110,653.0000 | 0 | 0.81% | 0.00% |
| March 8, 2023 | KYNTRA BIO, INC. | $KYNB | Wettig Thane | Chief Commercial Officer | A | COmmon Stock | 5799 | $0.00 | 109,889.0000 | 0 | 5.57% | 0.00% |
| March 10, 2023 | KYNTRA BIO, INC. | $KYNB | Wettig Thane | Chief Commercial Officer | S | Common Stock | 2938 | $20.20 | 116,289.0000 | 0 | 2.46% | 0.00% |
| March 10, 2023 | KYNTRA BIO, INC. | $KYNB | Wettig Thane | Chief Commercial Officer | S | Common Stock | 4731 | $20.20 | 111,558.0000 | 0 | 4.07% | 0.00% |
| March 8, 2023 | KYNTRA BIO, INC. | $KYNB | Wettig Thane | Chief Commercial Officer | S | Common Stock | 6265 | $21.16 | 104,090.0000 | 0 | 5.68% | 0.00% |
| March 8, 2023 | KYNTRA BIO, INC. | $KYNB | Wettig Thane | Chief Commercial Officer | A | Common Stock | 9338 | $0.00 | 119,227.0000 | 0 | 8.50% | 0.00% |
| Feb. 21, 2023 | KYNTRA BIO, INC. | $KYNB | Wettig Thane | Chief Commercial Officer | A | Stock Option (Right to Buy) | 42000 | $0.00 | 42,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 21, 2023 | KYNTRA BIO, INC. | $KYNB | Wettig Thane | Chief Commercial Officer | A | Common Stock | 25000 | $0.00 | 110,355.0000 | 0 | 29.29% | 0.00% |
| Aug. 22, 2022 | KYNTRA BIO, INC. | $KYNB | Wettig Thane | Chief Commercial Officer | G | Common Stock | 1820 | $0.00 | 85,355.0000 | 0 | 2.09% | 0.00% |
| May 25, 2022 | KYNTRA BIO, INC. | $KYNB | Wettig Thane | Chief Commercial Officer | G | Common Stock | 1988 | $0.00 | 87,175.0000 | 0 | 2.23% | 0.00% |
| May 25, 2022 | KYNTRA BIO, INC. | $KYNB | Wettig Thane | Chief Commercial Officer | G | Common Stock | 1988 | $0.00 | 87,175.0000 | 0 | 2.23% | 0.00% |